Alembic Pharmaceuticals is currently trading at Rs 1000.60, up by 10.95 points or 1.11% from its previous closing of Rs 989.65 on the BSE. The scrip opened at Rs 999.05 and has touched a high and low of Rs 1010.00 and Rs 980.00 respectively. So far 20842 shares were traded on the counter. The BSE … Read more
Alembic Pharmaceuticals is currently trading at Rs. 1078.25, up by 106.40 points or 10.95% from its previous closing of Rs. 971.85 on the BSE. The scrip opened at Rs. 1029.75 and has touched a high and low of Rs. 1089.80 and Rs. 990.20 respectively. So far 97681 shares were traded on the counter. The BSE … Read more
Alembic Pharmaceuticals has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Cyclophosphamide Capsules, 25 mg and 50 mg. he approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Cyclophosphamide Capsules, 25 mg and 50 mg, of Hikma Pharmaceuticals USA Inc. Cyclophosphamide … Read more
Alembic Pharmaceuticals is currently trading at Rs. 661.55, up by 49.35 points or 8.06% from its previous closing of Rs. 612.20 on the BSE. The scrip opened at Rs. 608.70 and has touched a high and low of Rs. 675.00 and Rs. 603.55 respectively. So far 143890 shares were traded on the counter. The BSE … Read more
Alembic Pharmaceuticals is currently trading at Rs. 735.70, up by 3.60 points or 0.49% from its previous closing of Rs. 732.10 on the BSE. The scrip opened at Rs. 730.00 and has touched a high and low of Rs. 740.90 and Rs. 728.90 respectively. So far 1704 shares were traded on the counter. The BSE … Read more
Alembic Pharmaceuticals is planning to raise funds on Private Placement Basis through issuance of Non-Convertible Debentures (NCDs). The Board of Directors of the Company at its meeting to be held on December 06, 2018 to consider the same. Alembic Pharmaceuticals, a vertically integrated research and development pharmaceutical company, has been at the forefront of Healthcare … Read more
